Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The apoptosis pathway in HPV-infected cells refers to the network of molecular mechanisms by which programmed cell death (apoptosis) is regulated or subverted during infection with human papillomavirus (HPV). High-risk HPVs inhibit both intrinsic and extrinsic apoptotic pathways, allowing infected cells to survive, proliferate, and potentially undergo malignant transformation. Key viral proteins involved include E5, E6, and E7, which target host proteins like p53, Bak/Bax, FADD, and caspases.
Targeting viral oncoproteins (E6/E7) to restore apoptotic sensitivity; restoring pro-apoptotic signals
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis pathway in HPV-infected cells.